Translational Drug Development (TD2)
Kristen Dempsey has a strong background in commercial development and marketing within the pharmaceutical and biotechnology industries. Kristen is currently the Senior Vice President of Commercial Development at Translational Drug Development (TD2), where they lead sales and marketing teams to identify and create new business opportunities. Prior to this role, they served as the Vice President of Marketing at TD2, where they focused on driving client success throughout the drug development process and expanding the market for TD2.
Before joining TD2, Kristen held various leadership positions at MilliporeSigma, Crown Bioscience, Inc., Horizon Discovery, SAGE Labs, and Sigma-Aldrich. In these roles, they were responsible for developing and executing strategic marketing and business development programs, expanding market share, managing teams, and launching new products. Kristen has extensive experience in driving growth and revenue through effective marketing strategies and collaborative partnerships.
Kristen Dempsey completed their Bachelor of Arts degree in Genetic Engineering from Southern Illinois University Edwardsville. Kristen pursued their education in this field from 1997 to 2000.
This person is not in any offices
Translational Drug Development (TD2)
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.